The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for JB Aggen


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Multivalent design of long-actingß(2)-adrenoceptor agonists incorporating biarylamines.EBI
Theravance
1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.EBI
Chemocentryx
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors.EBI
Revolution Medicines
Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitors.EBI
University of California Irvine
Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A.EBI
University of California Irvine
"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"BDB
Novartis